CEO: Sergio Traversa
Employees: 17
IPO: Jun 20, 2014
Precio
$6.96
Cambio
▲ $0.58
9.09%
Cap. Mercado
510.40M
Rango del Día
$6.38
$6.96
Rango de 52 Semanas
$0.24
$7.51
Volumen
2,185,032
Promedio 50D / 200D
$4.80
$2.83
Cierre Anterior
$6.38
Quick Summary
Puntos Clave
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -45.79M
PEG of 0.07 suggests growth is underpriced
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-94.05%
Below sector avg (3.68%)
ROIC-51.24%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.00
Below sector avg (0.24)
Current Ratio14.62
Interest Coverage0.00
Valoración
P/E Ratio
-8.89
Below sector avg (0.23)
Forward P/EN/A
P/B Ratio5.90
EV/EBITDAN/A
Dividend Yield0.00%
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (635 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -8.9 | 0.2 |
| P/B | 5.9 | 2.9 |
| ROE % | -94.1 | 3.7 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 9.6 |
| D/E | 0.0 | 0.2 |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -57.39M |
| ROE | -94.05% | ROA | -61.05% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -45.79M |
| ROIC | -51.24% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 14.62 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -8.89 | Forward P/E | N/A |
| P/B Ratio | 5.90 | P/S Ratio | N/A |
| PEG Ratio | 0.07 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -8.97% | ||
| Market Cap | 510.40M | Enterprise Value | 506.91M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -57.39M | -79.98M | -98.79M | -157.04M | -125.75M |
| EPS (Diluted) | -1.45 | -2.65 | -3.28 | -5.30 | -7.16 |
| Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -59.10M | -83.89M | -103.70M | -161.25M | -125.70M |
| EBITDA | -59.10M | -83.89M | 4.91M | -161.25M | -125.70M |
| R&D Expenses | 744,560.0 | 46.18M | 54.81M | 113.32M | 90.62M |
| SG&A Expenses | 311,904.0 | 37.72M | 48.90M | 47.93M | 35.08M |
| D&A | 0.0 | 0.0 | 103.70M | 2,000.0 | 1,258.0 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Income Tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 94.00M | 45.82M | 97.55M | 152.91M | 223.33M |
| Total Liabilities | 7.49M | 10.30M | 12.19M | 12.47M | 15.06M |
| Shareholders' Equity | 86.51M | 35.52M | 85.36M | 140.44M | 208.26M |
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash & Equivalents | 3.50M | 3.86M | 4.09M | 5.40M | 44.44M |
| Current Assets | 93.98M | 45.80M | 97.51M | 152.87M | 223.30M |
| Current Liabilities | 6.43M | 10.29M | 12.19M | 12.47M | 15.06M |